Tango Therapeutics's market cap is currently $261.03M. The company's EPS TTM is $-1.171; its P/E ratio is ―; Tango Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 36.53M	$ 24.86M	$ 37.04M	$ 7.66M	$ 24.65M
Gross Profit	$ -78.67M	$ 20.83M	$ 35.08M	$ 6.03M	$ -7.63M
Operating Income	$ -114.17M	$ -111.07M	$ -58.19M	$ -52.20M	$ -15.16M
EBITDA	$ -111.76M	$ -109.46M	$ -57.29M	$ -51.48M	$ -14.52M
Net Income	$ -101.74M	$ -108.18M	$ -58.23M	$ -51.86M	$ -14.10M
Balance Sheet
Cash & Short-Term Investments	$ 336.88M	$ 366.13M	$ 485.25M	$ 190.32M	$ 40.42M
Total Assets	$ 402.57M	$ 436.47M	$ 500.15M	$ 207.25M	$ 55.76M
Total Debt	$ 38.92M	$ 41.13M	$ 1.50M	$ 7.88M	$ 7.88M
Net Debt	$ -27.46M	$ -18.84M	$ -141.24M	$ -20.50M	$ -15.01M
Total Liabilities	$ 149.46M	$ 186.99M	$ 155.41M	$ 168.65M	$ 47.86M
Stockholders' Equity	$ 253.11M	$ 249.48M	$ 344.75M	$ 38.60M	$ 7.91M
Cash Flow
Free Cash Flow	$ -119.51M	$ -116.77M	$ -61.36M	$ 68.97M	$ -26.62M
Operating Cash Flow	$ -117.98M	$ -109.08M	$ -59.53M	$ 70.07M	$ -24.80M
Investing Cash Flow	$ 41.43M	$ 26.40M	$ -183.43M	$ -145.47M	$ 848.00K
Financing Cash Flow	$ 82.41M	$ 1.61M	$ 357.32M	$ 80.88M	$ 11.00M

Currency in USD

Tango Therapeutics Earnings and Revenue History

Income Statement >

Tango Therapeutics Debt to Assets

Balance Sheet >

Tango Therapeutics Cash Flow

Cash Flow >

Tango Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing